In contrast to labor intensive and destructive histological techniques, intrinsic autofluorescence lifetimes of extra cellular matrix proteins can provide label-free imaging of tissue modifications in diseases, including the diabetic ulcers. However, decoupling the complex mixture of tissue fluorophores requires costly and complicated fluorescent lifetime instrumentation. Furthermore, a list of autofluorescent and fluorogenic proteins must be characterized to profile their changes during disease progression. Towards these goals, an imaging system based on frequency domain light-emitting diode (LED) modulation was designed and demonstrated, using off-the-shelf components in a low complexity design. The system was operated by coupling and imaging fluorescence intensities using a pair of objectives. The system’s scanning and signal acquisition performances were optimized with respect to etendues. To study fluorescent proteins in diabetic ulcers, lifetimes from purified and pentosidine modified collagen I, collagen III, and elastin were measured. Pentosidine measurements showed a decrease in autofluorescent lifetimes while elevated collagen III in diabetic ulcers showed increased lifetimes. These lifetimes, plus future protein measurements enabled by our system, can serve as standards for developing a biophotonic model of diabetic ulcers. As a proof-of-concept, a 3 cm × 3 cm diabetic foot ulcer was imaged using the developed system. Phasor analysis was applied to aid the interpretation of lifetime images. As a result, a compact biophotonic imaging system targeting diabetic tissue was achieved, towards making the technique accessible for clinical histology.

1.
Z.
Deyl
,
K.
Macek
,
M.
Adam
, and
O.
Vancíková
, “
Studies on the chemical nature of elastin fluorescence
,”
Biochim. Biophys. Acta
625
(
2
),
248
254
(
1980
).
2.
D. R.
Eyre
,
M. A.
Paz
, and
P. M.
Gallop
, “
Cross-linking in collagen and elastin
,”
Annu. Rev. Biochem.
53
,
717
748
(
1984
).
3.
E.
Fujimori
, “
Changes induced by ozone and ultraviolet light in type I collagen: Bovine Achilles tendon collagen versus rat tail tendon collagen
,”
Eur. J. Biochem.
152
,
299
306
(
1985
).
4.
O.
Vančíková
and
Z.
Deyl
, “
Disappearance of tyrosine residues in collagen with age. Suggestion of a possible reaction mechanism
,”
Exp. Gerontol.
9
(
3
),
123
130
(
1974
).
5.
R.
Liu
,
Z.
Zhao
,
L.
Zou
,
Q.
Fang
,
L.
Chen
,
A.
Argento
, and
J. F.
Lo
, “
Compact, non-invasive frequency domain lifetime differentiation of collagens and elastin
,”
Sens. Actuators, B
219
,
283
293
(
2015
).
6.
L.
Zou
,
R.
Koslakiewicz
,
M.
Mahmoud
,
M.
Fahs
,
R.
Liu
, and
J. F.
Lo
, “
Three-dimensional printed miniaturized spectral system for collagen fluorescence lifetime measurements
,”
J. Biomed. Opt.
21
(
7
),
075001
(
2016
).
7.
L.
Marcu
,
D.
Cohen
,
J. M.
Maarek
, and
W. S.
Grundfest
, “
Characterization of type I, II, III, IV, and V collagens by time-resolved laser-induced fluorescence spectroscopy
,”
Proc. SPIE
3917
,
93
101
(
2000
).
8.
M. Y.
Berezin
and
S.
Achilefu
, “
Fluorescence lifetime measurements and biological imaging
,”
Chem. Rev.
110
(
5
),
2641
2684
(
2010
).
9.
J. E.
Phipps
,
Y.
Sun
,
M. C.
Fishbein
, and
L.
Marcu
, “
A fluorescence lifetime imaging classification method to investigate the collagen to lipid ratio in fibrous caps of atherosclerotic plaque
,”
Lasers Surg. Med.
44
(
7
),
564
571
(
2012
).
10.
S.
Ranjit
,
A.
Dvornikov
,
M.
Stakic
,
S. H.
Hong
,
M.
Levi
,
R. M.
Evans
, and
E.
Gratton
, “
Imaging fibrosis and separating collagens using second harmonic generation and phasor approach to fluorescence lifetime imaging
,”
Sci. Rep.
5
,
13378
(
2015
).
11.
J. R.
Lakowicz
,
Principles of Spectroscopy
, 3rd ed. (
Springer
,
New York
,
2007
).
12.
J. R.
Lakowicz
,
G.
Laczko
,
H.
Cherek
,
E.
Gratton
, and
M.
Limkeman
, “
Analysis of fluorescence decay kinetics from variable-frequency phase shift and modulation data
,”
Biophys. J.
46
(
4
),
463
477
(
1984
).
13.
I. A.
Darby
and
T. D.
Hewitson
, “
Fibroblast differentiation in wound healing and fibrosis
,”
Int. Rev. Cytol.
257
,
143
179
(
2007
).
14.
H. P.
Ehrlich
, “
The role of connective tissue matrix in wound healing
,”
Prog. Clin. Biol. Res.
266
,
243
258
(
1988
).
15.
M. J.
Ranzer
,
L.
Chen
, and
L. A.
DiPietro
, “
Fibroblast function and wound breaking strength are impaired by acute ethanol intoxication
,”
Alcohol.: Clin. Exp. Res.
35
,
83
90
(
2011
).
16.
J. R.
Merkel
,
B. R.
DiPaolo
,
G. G.
Hallock
, and
D. C.
Rice
, “
Type I and type III collagen content of healing wounds in fetal and adult rats
,”
Proc. Soc. Exp. Biol. Med.
187
,
493
497
(
1988
).
17.
J. F.
Almine
,
S. G.
Wise
, and
A. S.
Weiss
, “
Elastin signaling in wound repair
,”
Birth Defects Res., Part C
96
(
3
),
248
257
(
2012
).
18.
P.
Gkogkolou
and
M.
Böhm
, “
Advanced glycation end products: Key players in skin aging?
,”
Derm.-Endocrinol.
4
(
3
),
259
270
(
2012
).
19.
L.
Van Putte
,
S.
De Schrijver
, and
P.
Moortgat
, “
The effects of advanced glycation end products (AGEs) on dermal wound healing and scar formation: A systematic review
,”
Scars, Burns Healing
2
,
205951311667682
(
2016
).
20.
R.
Singh
,
A.
Barden
,
T.
Mori
, and
L.
Beilin
, “
Advanced glycation end-products: A review
,”
Diabetologia
44
(
2
),
129
146
(
2001
).
21.
N.
Ahmed
, “
Advanced glycation endproducts—Role in pathology of diabetic complications
,”
Diabetes Res. Clin. Pract.
67
(
1
),
3
21
(
2005
).
22.
M. S.
Huijberts
,
N. C.
Schaper
, and
C. G.
Schalkwijk
, “
Advanced glycation end products and diabetic foot disease
,”
Diabetes/Metab. Res. Rev.
24
(
S1
),
S19
(
2008
).
23.
M. T.
Goova
,
J.
Li
,
T.
Kislinger
,
W.
Qu
,
Y.
Lu
,
L. G.
Bucciarelli
,
S.
Nowygrod
,
B. M.
Wolf
,
X.
Caliste
,
S. F.
Yan
, and
D. M.
Stern
, “
Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice
,”
Am. J. Pathol.
159
(
2
),
513
525
(
2001
).
24.
C. P.
Wilkinson
,
F. L.
Ferris
,
R. E.
Klein
,
P. P.
Lee
,
C. D.
Agardh
,
M.
Davis
,
D.
Dills
,
A.
Kampik
,
R.
Pararajasegaram
,
J. T.
Verdaguer
, and
G. D.
Group
, “
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales
,”
Ophthalmology
110
(
9
),
1677
1682
(
2003
).
25.
L. P.
Aiello
,
R. L.
Avery
,
P. G.
Arrigg
,
B. A.
Keyt
,
H. D.
Jampel
,
S. T.
Shah
,
L. R.
Pasquale
,
H.
Thieme
,
M. A.
Iwamoto
,
J. E.
Park
, and
H. V.
Nguyen
, “
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
,”
N. Engl. J. Med.
331
(
22
),
1480
1487
(
1994
).
26.
R. A.
Malik
,
S.
Tesfaye
,
S. D.
Thompson
,
A.
Veves
,
A. K.
Sharma
,
A. J.
Boulton
, and
J. D.
Ward
, “
Endoneurial localisation of microvascular damage in human diabetic neuropathy
,”
Diabetologia
36
(
5
),
454
459
(
1993
).
27.
A. M.
Vincent
,
B. C.
Callaghan
,
A. L.
Smith
, and
E. L.
Feldman
, “
Diabetic neuropathy: Cellular mechanisms as therapeutic targets
,”
Nat. Rev. Neurol.
7
(
10
),
573
583
(
2011
).
28.
J. L.
Edwards
,
A. M.
Vincent
,
H. T.
Cheng
, and
E. L.
Feldman
, “
Diabetic neuropathy: Mechanisms to management
,”
Pharmacol. Ther.
120
(
1
),
1
34
(
2008
).
29.
R. J.
Johnson
,
M. S.
Segal
,
Y.
Sautin
,
T.
Nakagawa
,
D. I.
Feig
,
D. H.
Kang
,
M. S.
Gersch
,
S.
Benner
, and
L. G.
Sánchez-Lozada
, “
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease
,”
Am. J. Clin. Nutr.
86
(
4
),
899
906
(
2007
).
30.
B. M.
Brenner
,
M. E.
Cooper
,
D.
de Zeeuw
,
W. F.
Keane
,
W. E.
Mitch
,
H. H.
Parving
,
G.
Remuzzi
,
S. M.
Snapinn
,
Z.
Zhang
, and
S.
Shahinfar
, “
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
,”
N. Engl. J. Med.
345
(
12
),
861
869
(
2001
).
31.
H. H.
Parving
,
U.
Smidt
,
A.
Andersen
, and
P.
Svendsen
, “
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy
,”
Lancet
321
(
8335
),
1175
1179
(
1983
).
32.
V.
Falanga
, “
Wound healing and its impairment in the diabetic foot
,”
Lancet
366
(
9498
),
1736
1743
(
2005
).
33.
D.
Lu
,
B.
Chen
,
Z.
Liang
,
W.
Deng
,
Y.
Jiang
,
S.
Li
,
J.
Xu
,
Q.
Wu
,
Z.
Zhang
,
B.
Xie
, and
S.
Chen
, “
Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial
,”
Diabetes Res. Clin. Pract.
92
(
1
),
26
36
(
2011
).
34.
L. S.
Barcelos
,
C.
Duplaa
,
N.
Kränkel
,
G.
Graiani
,
G.
Invernici
,
R.
Katare
,
M.
Siragusa
,
M.
Meloni
,
I.
Campesi
,
M.
Monica
, and
A.
Simm
, “
Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling
,”
Circ. Res.
104
(
9
),
1095
1102
(
2009
).
35.
I. M.
Stratton
,
A. I.
Adler
,
H. A.
Neil
,
D. R.
Matthews
,
S. E.
Manley
,
C. A.
Cull
,
D.
Hadden
,
R. C.
Turner
, and
R. R.
Holman
, “
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
,”
BMJ
321
(
7258
),
405
412
(
2000
).
36.
A. I.
Adler
,
E. J.
Boyko
,
J. H.
Ahroni
, and
D. G.
Smith
, “
Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers
,”
Diabetes Care
22
(
7
),
1029
1035
(
1999
).
37.
D.
Jay
,
H.
Hitomi
, and
K. K.
Griendling
, “
Oxidative stress and diabetic cardiovascular complications
,”
Free Radical Biol. Med.
40
(
2
),
183
192
(
2006
).
38.
L.
Park
,
K. G.
Raman
,
K. J.
Lee
,
Y.
Lu
,
L. J.
Ferran
,
W. S.
Chow
,
D.
Stern
, and
A. M.
Schmidt
, “
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
,”
Nat. Med.
4
(
9
),
1025
(
1998
).
39.
S. Y.
Goh
and
M. E.
Cooper
, “
The role of advanced glycation end products in progression and complications of diabetes
,”
J. Clin. Endocrinol. Metab.
93
(
4
),
1143
1152
(
2008
).
40.
D.
Yao
and
M.
Brownlee
, “
Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands
,”
Diabetes
59
(
1
),
249
255
(
2010
).
41.
I.
Giardino
,
D.
Edelstein
, and
M.
Brownlee
, “
BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells
,”
J. Clin. Invest.
97
(
6
),
1422
(
1996
).
42.
G.
Basta
,
A. M.
Schmidt
, and
R.
De Caterina
, “
Advanced glycation end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes
,”
Cardiovasc. Res.
63
(
4
),
582
592
(
2004
).
43.
M.
Brownlee
,
H.
Vlassara
,
A.
Kooney
,
P.
Ulrich
, and
A.
Cerami
, “
Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking
,”
Science
232
,
1629
1633
(
1986
).
44.
R.
Candido
,
J. M.
Forbes
,
M. C.
Thomas
,
V.
Thallas
,
R. G.
Dean
,
W. C.
Burns
,
C.
Tikellis
,
R. H.
Ritchie
,
S. M.
Twigg
,
M. E.
Cooper
, and
L. M.
Burrell
, “
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes
,”
Circ. Res.
92
(
7
),
785
792
(
2003
).
45.
K.
Wang
,
Z.
Zhou
,
M.
Zhang
,
L.
Fan
,
F.
Forudi
,
X.
Zhou
,
W.
Qu
,
A. M.
Lincoff
,
A. M.
Schmidt
,
E. J.
Topol
, and
M. S.
Penn
, “
Peroxisome proliferator-activated receptor γ down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model
,”
J. Pharmacol. Exp. Ther.
317
(
1
),
37
43
(
2006
).
46.
M.
Alikhani
,
Z.
Alikhani
,
C.
Boyd
,
C. M.
MacLellan
,
M.
Raptis
,
R.
Liu
,
N.
Pischon
,
P. C.
Trackman
,
L.
Gerstenfeld
, and
D. T.
Graves
, “
Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways
,”
Bone
40
(
2
),
345
353
(
2007
).
47.
M. A.
Loots
,
E. N.
Lamme
,
J.
Zeegelaar
,
J. R.
Mekkes
,
J. D.
Bos
, and
E.
Middelkoop
, “
Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds
,”
J. Invest. Dermatol.
111
(
5
),
850
857
(
1998
).
48.
K. A.
Gallagher
,
Z. J.
Liu
,
M.
Xiao
,
H.
Chen
,
L. J.
Goldstein
,
D. G.
Buerk
,
A.
Nedeau
,
S. R.
Thom
, and
O. C.
Velazquez
, “
Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1α
,”
J. Clin. Invest.
117
(
5
),
1249
(
2007
).
49.
G. B.
Sajithlal
,
P.
Chithra
, and
G.
Chandrakasan
, “
Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats
,”
Biochem. Pharmacol.
56
(
12
),
1607
1614
(
1998
).
50.
N.
Verzijl
,
J.
DeGroot
,
C. B.
Zaken
,
O.
Braun-Benjamin
,
A.
Maroudas
,
R. A.
Bank
,
J.
Mizrahi
,
C. G.
Schalkwijk
,
S. R.
Thorpe
,
J. W.
Baynes
, and
J. W.
Bijlsma
, “
Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: A possible mechanism through which age is a risk factor for osteoarthritis
,”
Arthritis Rheumatol.
46
(
1
),
114
123
(
2002
).
51.
D. G.
Dyer
,
J. A.
Blackledge
,
S. R.
Thorpe
, and
J. W.
Baynes
, “
Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo
,”
J. Biol. Chem.
266
(
18
),
11654
11660
(
1991
).
52.
R.
Meerwaldt
,
J. W.
Hartog
,
R.
Graaff
,
R. J.
Huisman
,
T. P.
Links
,
N. C.
den Hollander
,
S. R.
Thorpe
,
J. W.
Baynes
,
G.
Navis
,
R. O.
Gans
, and
A. J.
Smit
, “
Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients
,”
J. Am. Soc. Nephrol.
16
(
12
),
3687
3693
(
2005
).
53.
S.
Fantini
,
M. A.
Franceschini
,
J.
Maier
,
S.
Walker
,
B.
Barbieri
, and
E.
Gratton
, “
Frequency-domain multichannel optical-detector for noninvasive tissue spectroscopy and oximetry
,”
Opt. Eng.
34
(
1
),
32
(
1995
).
54.
W. J.
O’Hagan
,
M.
McKenna
,
D. C.
Sherrington
,
O. J.
Rolinski
, and
D. J.
Birch
, “
MHz LED source for nanosecond fluorescence sensing
,”
Meas. Sci. Technol.
13
(
1
),
84
(
2001
).
55.
A. D.
Elder
,
J. H.
Frank
,
J.
Swartling
,
X.
Dai
, and
C. F.
Kaminski
,
“Calibration of a wide-field frequency-domain fluorescence lifetime microscopy system using light emitting diodes as light sources
,”
J. Microsc.
224
(
2
),
166
180
(
2006
).
56.
B.
Yuan
,
S. R.
McClellan
,
B. F.
Al-Mifgai
,
E. A.
Growney
, and
O. A.
Komolafe
, “
A cost-efficient frequency domain fluorescence lifetime measurement system
,”
Am. J. Phys.
78
(
1
),
28
34
(
2010
).
57.
F.
Ponten
,
B.
Berne
,
Z. P.
Ren
,
M.
Nistér
, and
J.
Ponten
, “
Ultraviolet light induces expression of p53 and p21 in human skin: Effect of sunscreen and constitutive p21 expression in skin appendages
,”
J. Invest. Dermatol.
105
(
3
),
402
406
(
1995
).
58.
C.
Marionnet
,
C.
Tricaud
, and
F.
Bernerd
, “
Exposure to non-extreme solar UV daylight: Spectral characterization, effects on skin and photoprotection
,”
Int. J. Mol. Sci.
16
(
1
),
68
90
(
2014
).
59.
S. R.
Chary
and
R. K.
Jain
, “
Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching
,”
Proc. Natl. Acad. Sci. U. S. A.
86
(
14
),
5385
5389
(
1989
).
60.
M. A.
Digman
,
V. R.
Caiolfa
,
M.
Zamai
, and
E.
Gratton
, “
The phasor approach to fluorescence lifetime imaging analysis
,”
Biophys. J.
94
(
2
),
L14
L16
(
2008
).
61.
C.
Stringari
,
A.
Cinquin
,
O.
Cinquin
,
M. A.
Digman
,
P. J.
Donovan
, and
E.
Gratton
, “
Phasor approach to fluorescence lifetime microscopy distinguishes different metabolic states of germ cells in a live tissue
,”
Proc. Natl. Acad. Sci. U. S. A.
108
(
33
),
13582
13587
(
2011
).
62.
C.
Stringari
,
R. A.
Edwards
,
K. T.
Pate
,
M. L.
Waterman
,
P. J.
Donovan
, and
E.
Gratton
, “
Metabolic trajectory of cellular differentiation in small intestine by Phasor Fluorescence Lifetime Microscopy of NADH
,”
Sci. Rep.
2
,
568
(
2012
).
63.
C. P.
Shillaber
,
Photomicrography in Theory and Practice
(
John Wiley and Sons
,
New York
,
1944
), p.
773
.
64.
D.
Schweitzer
,
L.
Deutsch
,
M.
Klemm
,
S.
Jentsch
,
M.
Hammer
,
S.
Peters
,
J.
Haueisen
,
U. A.
Müller
, and
J.
Dawczynski
, “
Fluorescence lifetime imaging ophthalmoscopy in type 2 diabetic patients who have no signs of diabetic retinopathy
,”
J. Biomed. Opt.
20
(
6
),
061106
(
2015
).
65.
J.
Schmidt
,
S.
Peters
,
L.
Sauer
,
D.
Schweitzer
,
M.
Klemm
,
R.
Augsten
,
N.
Müller
, and
M.
Hammer
, “
Fundus autofluorescence lifetimes are increased in non-proliferative diabetic retinopathy
,”
Acta Ophthalmol.
95
(
1
),
33
40
(
2017
).
66.
J.
Blackwell
,
K. M.
Katika
,
L.
Pilon
,
K. M.
Dipple
,
S. R.
Levin
, and
A.
Nouvong
, “
In vivo time-resolved autofluorescence measurements to test for glycation of human skin
,”
J. Biomed. Opt.
13
(
1
),
014004
(
2008
).
You do not currently have access to this content.